<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-WBJFXCF9/7c706400-2260-4401-84be-0b7a7a4a601a/PDF"><dcterms:extent>126 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-WBJFXCF9/f87f2620-fcbc-4e2a-8165-771692e18a41/TEXT"><dcterms:extent>26 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-WBJFXCF9"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>2001</dcterms:issued><dc:creator>Cör, Andrej</dc:creator><dc:creator>Pižem, Jože</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:40</dc:format><dc:format xml:lang="sl">str. 283-291</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:14497497</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-WBJFXCF9</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="en">Apoptosis</dc:subject><dc:subject xml:lang="sl">Apoptoza</dc:subject><dc:subject xml:lang="en">Aspartam</dc:subject><dc:subject xml:lang="en">Aspartame</dc:subject><dc:subject xml:lang="sl">biokemija</dc:subject><dc:subject xml:lang="sl">CD8-pozitivni limfociti T</dc:subject><dc:subject xml:lang="sl">celice</dc:subject><dc:subject xml:lang="sl">Celice ubijalke naravne</dc:subject><dc:subject xml:lang="sl">Citokini</dc:subject><dc:subject xml:lang="en">Cysteine proteinases</dc:subject><dc:subject xml:lang="en">Cytokines</dc:subject><dc:subject xml:lang="sl">fiziologija</dc:subject><dc:subject xml:lang="sl">kaspaze</dc:subject><dc:subject xml:lang="en">Killer cells, natural</dc:subject><dc:subject xml:lang="en">T-lymphocytes, cytotoxic</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q7094" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Kaspaze| Caspases|</dc:title><dc:description xml:lang="sl">Caspases are cysteine proteases, which cleave their substrates following an aspartate residue. They are present as inactive precursors (pro-caspases) in cells. Caspases are involved in cytokine processing and apoptosis (programmed cell death) regulation. Apoptotic caspases are activator caspases (caspases 8 and 9) or effector caspases (caspases 3 and 7). Apoptosis can be initiated by either extracellular or intracellular pathways. Extracellular signals mediate apoptosis by death receptors, which activate caspase 8. Intracellular signals provoke changes in the permeability of the outer mitochondrial membrane which permits cytochrome C release from mitochondria. In the cytosol, cytochrome C allows activation of caspase 9. Activated caspases 8 and/or 9 induce cascade activation of effector caspases which cleave different target proteins. Demolition of target proteins plays an important role in morphological changesof apoptotic cells</dc:description><dc:description xml:lang="sl">Kaspaze so cisteinske proteaze, ki cepijo peptidno verigo za aminokislino aspartatom. V celicah so prisotne v neaktivni obliki (prokaspaze). Sodelujejo pri procesiranju citokinov in igrajo osrednjo vlogo pri uravnavanju apoptoze (programirane celične smrti). Kaspaze, ki sodelujejo pri apoptozi, delimo v aktivatorske (kaspazi 8 in 9) in efektorske (kaspazi 3 in 7). Apoptozo lahko sprožijo različni zunajcelični ali znotrajcelični signali. Zunajcelični signali delujejo preko receptorjev smrti in aktivirajo kaspazo 8, znotrajcelični (poškodba celice) pa povzročijo sproščanje citokroma C iz mitohondrijev, kar vodi v aktivacijo kaspaze 9. Aktivirani kaspazi 8 in/ali 9 sprožita kaskadno aktivacijo efektorskih kaspaz, te pa cepijo različne celičnebeljakovine - kaspazne substrate. Razgradnja celičnih beljakovin je odgovorna za značilne morfološke spremembe apoptotskih celic</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-WBJFXCF9"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-WBJFXCF9" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-WBJFXCF9/7c706400-2260-4401-84be-0b7a7a4a601a/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-WBJFXCF9/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-WBJFXCF9" /></ore:Aggregation></rdf:RDF>